Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study
To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. The population-based follow-up Guangzhou Heart Study collected baseline data from J...
Saved in:
Published in | BMC cardiovascular disorders Vol. 19; no. 1; pp. 270 - 8 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
28.11.2019
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China.
The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence.
The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016).
In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women. |
---|---|
AbstractList | To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016). In Guangzhou, China, prevalence of EBG is high among residents aged 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women. Abstract Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. Methods The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. Results The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40–2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14–2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12–2.91, P = 0.016). Conclusions In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women. To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016). In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women. Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. Methods The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. Results The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40–2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14–2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12–2.91, P = 0.016). Conclusions In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women. To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China.BACKGROUNDTo estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China.The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence.METHODSThe population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged > 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence.The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016).RESULTSThe prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016).In Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women.CONCLUSIONSIn Guangzhou, China, prevalence of EBG is high among residents aged > 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women. Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with non-valvular atrial fibrillation (NVAF) in Guangzhou, China. Methods The population-based follow-up Guangzhou Heart Study collected baseline data from July 2015 to August 2017 among 12,013 permanent residents aged 35 from 4 Guangzhou districts. Two streets (Dadong and Baiyun) in the Yuexiu District, and one street (Xiaoguwei) and two towns (Xinzao and Nancun) in the Panyu District were chosen as representative of urban and rural areas, respectively. Each participant completed a comprehensive questionnaire, and underwent physical examination, blood sample collection for laboratory testing, electrocardiography, and other evaluations. Multivariable logistic regression analyses were used to estimate the independent association between hyperglycemia and NVAF prevalence. Results The prevalence of EBG in overall study population was 29.9%. Compared with residents without EBG, the odds ratio (OR) for AF among residents with EBG was significantly higher (1.94, 95% confidence interval [CI]: 1.40-2.70, P < 0.001), even after multivariate adjustment for metabolic abnormalities (OR = 1.60, 95% CI: 1.14-2.25, P = 0.007), and driven by women (OR = 1.80, 95% CI: 1.12-2.91, P = 0.016). Conclusions In Guangzhou, China, prevalence of EBG is high among residents aged 35 years and associated with a multivariate adjusted increase in prevalence of NVAF overall and in women. Keywords: Hyperglycemia, Type 2 diabetes mellitus, Impaired fasting glucose, Non-valvular atrial fibrillation, Sex |
ArticleNumber | 270 |
Audience | Academic |
Author | Wu, Shu-lin Wei, Wei Fu, Zu-yi Liu, Yang Liu, Fang-zhou Zhan, Xian-zhang Fang, Xian-hong Liao, Hong-tao Tang, Li-hong Zheng, Mu-rui Deng, Hai Xue, Yu-mei Fu, Lu Liao, Zi-li He, Shang-fei Lin, Wei-dong |
Author_xml | – sequence: 1 givenname: Lu surname: Fu fullname: Fu, Lu – sequence: 2 givenname: Hai surname: Deng fullname: Deng, Hai – sequence: 3 givenname: Wei-dong surname: Lin fullname: Lin, Wei-dong – sequence: 4 givenname: Shang-fei surname: He fullname: He, Shang-fei – sequence: 5 givenname: Fang-zhou surname: Liu fullname: Liu, Fang-zhou – sequence: 6 givenname: Yang surname: Liu fullname: Liu, Yang – sequence: 7 givenname: Xian-zhang surname: Zhan fullname: Zhan, Xian-zhang – sequence: 8 givenname: Xian-hong surname: Fang fullname: Fang, Xian-hong – sequence: 9 givenname: Hong-tao surname: Liao fullname: Liao, Hong-tao – sequence: 10 givenname: Wei surname: Wei fullname: Wei, Wei – sequence: 11 givenname: Zi-li surname: Liao fullname: Liao, Zi-li – sequence: 12 givenname: Li-hong surname: Tang fullname: Tang, Li-hong – sequence: 13 givenname: Zu-yi surname: Fu fullname: Fu, Zu-yi – sequence: 14 givenname: Mu-rui surname: Zheng fullname: Zheng, Mu-rui – sequence: 15 givenname: Shu-lin surname: Wu fullname: Wu, Shu-lin – sequence: 16 givenname: Yu-mei orcidid: 0000-0001-7354-0014 surname: Xue fullname: Xue, Yu-mei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31779588$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kk1vEzEQhleoiH7AD-CCLHHhssUfu7aXA1JUtaVSJS5wtrz2OHHkrIO9m6oc-O04SQtNBfLB1sw7j2dG72l1NMQBquotweeESP4xEyoFrTHpakJbVvMX1QlpBKkp5eToyfu4Os15iTEREnevqmNGhOhaKU-qX7Oco_F69HFAPYx3AAOCABs9gkV9iNGieZhMzIBKFALSg0Wlj3qjw2YKOiE9Jq8Dcr5PPoQd6RPSKME6phG5FFdoXAC6nvQw_7mIE1qALok8Tvb-dfXS6ZDhzcN9Vn2_uvx28aW-_Xp9czG7rU3L8VizRmMJjnROWCLBtLqXhJEGCNbGtT3nFEssCaWCNU2ZUWjroHEMd5ZSZ9hZdbPn2qiXap38Sqd7FbVXu0BMc1V68iaAYqLhPbSm8HBDudVSENN0vTW67VstCuvznrWe-hVYA8OYdDiAHmYGv1DzuFFcSsZlVwAfHgAp_pggj2rls4GyuwHilBVlFDPRdR0r0vfPpMs4paGsaquStGOtoH9Vc10G8IOL5V-zhaoZx6IhDZFb1fk_VOVYWHlTnOV8iR8UvHs66J8JH91TBGIvMCnmnMAp48edAQrZB0Ww2vpU7X2qik_V1qeKl0ryrPIR_v-a3w-P6j0 |
CitedBy_id | crossref_primary_10_1002_joa3_12938 crossref_primary_10_3390_mca29050084 crossref_primary_10_3389_fendo_2022_895843 crossref_primary_10_3390_medicina57121357 crossref_primary_10_26599_1671_5411_2023_04_008 crossref_primary_10_4103_hm_HM_D_23_00028 crossref_primary_10_1186_s12933_021_01216_7 crossref_primary_10_4239_wjd_v14_i8_1163 crossref_primary_10_2147_CLEP_S399920 |
Cites_doi | 10.7326/0003-4819-150-9-200905050-00006 10.1016/S0140-6736(05)66375-1 10.1016/j.jacc.2012.06.030 10.1016/S0140-6736(09)60443-8 10.1016/j.ahj.2013.08.012 10.1093/qjmed/hcm044 10.1093/eurheartj/ehm400 10.1056/NEJM198204293061703 10.1016/S0002-9343(02)01236-6 10.1016/j.ijcard.2018.02.051 10.1161/01.HYP.0000146691.51307.84 10.1378/chest.14-0321 10.1016/S0140-6736(98)07037-8 10.1161/CIRCULATIONAHA.105.595140 10.1016/S0002-9149(98)00736-X 10.1161/CIRCULATIONAHA.109.192644 10.1093/eurheartj/ehx316 10.1016/j.amjcard.2011.03.004 10.1161/01.CIR.0000140263.20897.42 10.2337/diacare.28.suppl_1.S37 10.1038/s41598-018-35928-w 10.1161/CIRCULATIONAHA.113.005119 10.1016/j.ijcard.2005.02.050 10.1161/CIR.0000000000000040 10.2188/jea.JE2008021 10.1016/j.jacc.2006.08.060 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12872-019-1253-6 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2261 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_3746be5c8080426da871c49bdca5b5a7 PMC6883689 A607414182 31779588 10_1186_s12872_019_1253_6 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China Guangzhou China |
GeographicLocations_xml | – name: China – name: Guangzhou China |
GrantInformation_xml | – fundername: ; grantid: 2014Y2-00196; 201508020261 – fundername: ; grantid: 81870254 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS ECGQY EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PMFND 3V. 7QP 7XB 8FK AZQEC DWQXO EJD K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c560t-34a08ef19f7d18ec5ab81314e10acf5b662080812273448097adfe4f309d22fc3 |
IEDL.DBID | M48 |
ISSN | 1471-2261 |
IngestDate | Wed Aug 27 01:30:39 EDT 2025 Thu Aug 21 17:18:50 EDT 2025 Thu Jul 10 18:10:56 EDT 2025 Fri Jul 25 22:44:09 EDT 2025 Tue Jun 17 21:30:19 EDT 2025 Tue Jun 10 20:19:15 EDT 2025 Thu Apr 03 07:02:33 EDT 2025 Tue Jul 01 02:37:50 EDT 2025 Thu Apr 24 23:09:11 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Hyperglycemia Impaired fasting glucose Type 2 diabetes mellitus Non-valvular atrial fibrillation Sex |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c560t-34a08ef19f7d18ec5ab81314e10acf5b662080812273448097adfe4f309d22fc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7354-0014 |
OpenAccessLink | https://www.proquest.com/docview/2328293572?pq-origsite=%requestingapplication% |
PMID | 31779588 |
PQID | 2328293572 |
PQPubID | 44077 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_3746be5c8080426da871c49bdca5b5a7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6883689 proquest_miscellaneous_2320379993 proquest_journals_2328293572 gale_infotracmisc_A607414182 gale_infotracacademiconefile_A607414182 pubmed_primary_31779588 crossref_citationtrail_10_1186_s12872_019_1253_6 crossref_primary_10_1186_s12872_019_1253_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-11-28 |
PublicationDateYYYYMMDD | 2019-11-28 |
PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC cardiovascular disorders |
PublicationTitleAlternate | BMC Cardiovasc Disord |
PublicationYear | 2019 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | SS Chugh (1253_CR3) 2014; 129 WS Leslie (1253_CR14) 2007; 100 AS Gami (1253_CR24) 2007; 49 D Gu (1253_CR10) 2005; 365 S Stewart (1253_CR2) 2002; 113 RB Schnabel (1253_CR6) 2009; 373 UK Prospective Diabetes Study (UKPDS) Group (1253_CR12) 1998; 352 CT January (1253_CR18) 2014; 130 MM Gallagher (1253_CR17) 1998; 82 DM Lloyd-Jones (1253_CR23) 2004; 110 AS Levey (1253_CR21) 2009; 150 H Deng (1253_CR15) 2018; 8 MR Movahed (1253_CR25) 2005; 105 KG Alberti (1253_CR20) 2009; 120 American Diabetes Association (1253_CR19) 2005; 28 WB Kannel (1253_CR1) 1982; 306 P Korantzopoulos (1253_CR5) 2005; 293 T Schoen (1253_CR28) 2012; 60 Y Li (1253_CR7) 2018; 261 SS Lee (1253_CR9) 2017; 38 L Niskanen (1253_CR13) 2004; 44 EJ Benjamin (1253_CR4) 1994; 271 R Latini (1253_CR27) 2013; 166 Z Zhou (1253_CR16) 2008; 18 Y Miyasaka (1253_CR22) 2006; 114 Y Guo (1253_CR26) 2015; 147 RR Huxley (1253_CR8) 2011; 108 D Conen (1253_CR11) 2007; 28 |
References_xml | – volume: 150 start-page: 604 year: 2009 ident: 1253_CR21 publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-9-200905050-00006 – volume: 365 start-page: 1398 year: 2005 ident: 1253_CR10 publication-title: Lancet doi: 10.1016/S0140-6736(05)66375-1 – volume: 293 start-page: 1974 year: 2005 ident: 1253_CR5 publication-title: JAMA – volume: 60 start-page: 1421 year: 2012 ident: 1253_CR28 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.06.030 – volume: 373 start-page: 739 year: 2009 ident: 1253_CR6 publication-title: Lancet doi: 10.1016/S0140-6736(09)60443-8 – volume: 166 start-page: 935 year: 2013 ident: 1253_CR27 publication-title: Am Heart J doi: 10.1016/j.ahj.2013.08.012 – volume: 100 start-page: 395 year: 2007 ident: 1253_CR14 publication-title: Q J Med doi: 10.1093/qjmed/hcm044 – volume: 28 start-page: 2937 year: 2007 ident: 1253_CR11 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehm400 – volume: 306 start-page: 1018 year: 1982 ident: 1253_CR1 publication-title: N Engl J Med doi: 10.1056/NEJM198204293061703 – volume: 113 start-page: 359 year: 2002 ident: 1253_CR2 publication-title: Am J Med doi: 10.1016/S0002-9343(02)01236-6 – volume: 261 start-page: 92 year: 2018 ident: 1253_CR7 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2018.02.051 – volume: 44 start-page: 859 year: 2004 ident: 1253_CR13 publication-title: Hypertension doi: 10.1161/01.HYP.0000146691.51307.84 – volume: 271 start-page: 840 year: 1994 ident: 1253_CR4 publication-title: Framingham Heart Study JAMA – volume: 147 start-page: 109 year: 2015 ident: 1253_CR26 publication-title: Chest doi: 10.1378/chest.14-0321 – volume: 352 start-page: 854 year: 1998 ident: 1253_CR12 publication-title: Lancet doi: 10.1016/S0140-6736(98)07037-8 – volume: 114 start-page: 119 year: 2006 ident: 1253_CR22 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.595140 – volume: 82 start-page: 18N year: 1998 ident: 1253_CR17 publication-title: Am J Cardiol doi: 10.1016/S0002-9149(98)00736-X – volume: 120 start-page: 1640 year: 2009 ident: 1253_CR20 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192644 – volume: 38 start-page: 2599 year: 2017 ident: 1253_CR9 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx316 – volume: 108 start-page: 56 year: 2011 ident: 1253_CR8 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2011.03.004 – volume: 110 start-page: 1042 year: 2004 ident: 1253_CR23 publication-title: Circulation doi: 10.1161/01.CIR.0000140263.20897.42 – volume: 28 start-page: S37 issue: Suppl 1 year: 2005 ident: 1253_CR19 publication-title: Diab Care doi: 10.2337/diacare.28.suppl_1.S37 – volume: 8 start-page: 17829 year: 2018 ident: 1253_CR15 publication-title: Sci Rep doi: 10.1038/s41598-018-35928-w – volume: 129 start-page: 837 year: 2014 ident: 1253_CR3 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.005119 – volume: 105 start-page: 315 year: 2005 ident: 1253_CR25 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2005.02.050 – volume: 130 start-page: 2071 year: 2014 ident: 1253_CR18 publication-title: Circulation doi: 10.1161/CIR.0000000000000040 – volume: 18 start-page: 209 year: 2008 ident: 1253_CR16 publication-title: J Epidemiol doi: 10.2188/jea.JE2008021 – volume: 49 start-page: 565 year: 2007 ident: 1253_CR24 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.08.060 |
SSID | ssj0017809 |
Score | 2.2605731 |
Snippet | To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its association with... Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its... Abstract Background To estimate the prevalence of elevated blood glucose level (EBG, including type 2 diabetes mellitus and impaired fasting glucose), and its... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 270 |
SubjectTerms | Adult Age Age Factors Aged Alcohol Analysis Atrial fibrillation Atrial Fibrillation - diagnosis Atrial Fibrillation - epidemiology Biomarkers - blood Blood glucose Blood Glucose - analysis Blood pressure Blood tests Cardiac arrhythmia Cardiovascular disease China - epidemiology Cholesterol Chronic obstructive pulmonary disease Cities and towns Cross-Sectional Studies Data collection Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - epidemiology EKG Electrocardiography Fasting Female Fibrillation Glucose Glucose Intolerance - blood Glucose Intolerance - diagnosis Glucose Intolerance - epidemiology Health risk assessment Heart Heart attacks Humans Hyperglycemia Hypertension Hyperthyroidism Impaired fasting glucose Kidney diseases Male Males Metabolic disorders Middle Aged Non-valvular atrial fibrillation Population Population studies Prevalence Prognosis Questionnaires Regression analysis Risk Assessment Risk Factors Rural areas Sex Sex Factors Substance abuse treatment Time Factors Type 2 diabetes Type 2 diabetes mellitus Up-Regulation Womens health |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxUxFA7ShbgR345WiSAIQmgyeY67KpYi1JWF7kJeY4XLtNh7Xbjwt3tOJvdyB0E3LmeSGfI4yflCvvMdQl6rZIac88gSj4bBk2aut5qlLPC1VKaGj519Nqfn6tOFvthL9YWcsFkeeB64I2mViUUn1D8Eb5IDIPykhphT0FGHGkcOPm97mGr3B9bxod1hCmeObmAXtkhBQOl_LZlZeKEq1v_nlrznk5Z8yT0HdHKP3G3IkR7PLb5PbpXpAbl91u7GH5JfeyNNG_2KYvQ4oMlMK0GdNoI6XSFViIYpUzj9MzC2H8hGpaHm8KAjhgGsZpLcOxrofK9AMRKFAl6kYFbT15-XVxuK6bDXtErUPiLnJx-_fDhlLbsCS4By1kyqwF0ZxTDaLFxJOkQnpFBF8JBGHY3pOabl6FEAR8F42pDHokbJh9z3Y5KPyQG0sTwlVBWN5BO8guRKCBMBBOg-BvD98OdedYRvR9unJj2OGTBWvh5BnPHzBHmYII8T5E1H3u4-uZ51N_5W-T1O4a4iSmbXF2BIvhmS_5chdeQNGoDHhQ2NS6HFJ0AXUSLLHxtEXwrOYx05XNSEBZmWxVsT8m1DuPEAXB0gK22h-NWuGL9EkttUrja1DpcWELvsyJPZ4nZdAphnB-1cR-zCFhd9XpZM3y6rXLhxTho3PPsfg_Sc3OnrKhKsd4fkYP19U14AKlvHl3UB_gayVjSj priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LixQxEA66gngR37auEkEQhLCdd9qLrOKyCOvJhbmFdNK9Kwzd686MBw_-dqvSmXEaYY_TSQ95VJIvXV99RchbFU2TUupZrFvD4JdmTljNYuL4WCqTw8fOvpnTc_V1oRflg9uq0Cq3e2LeqNMY8Rv5EZz8Do4mbcXHq58Ms0ahd7Wk0LhN7qB0GVq1XewuXNy6uimeTO7M0Qr2YotEBEwAoCUzs7MoS_b_vzHvnUxz1uTeMXTygNwv-JEeTxP-kNzqhkfk7lnxkD8mf_bGmxYSFsUYcsCUiWaaOi00dbpEwhANQ6LDODAwuV_ISaUhZ_KgPQYDLCeq3Aca6ORdoBiPQgE1UjCu4eL35bihmBR7TbNQ7RNyfvLl--dTVnIssAhYZ82kCrXret70NnHXRR1axyVXHa9D7HVrjKgxOYdAGRwF42lD6jvVy7pJQvRRPiUH0MbuOaGq00hBQUdkrTg3LUABLdoACAD-WaiK1NvR9rEIkGMejKXPFxFn_DRBHibI4wR5U5H3u1euJvWNmyp_wincVUTh7PxgvL7wZR16aZVpOx1RThPASQpwYYyqaVMMutXBVuQdGoDH5Q2Ni6FEKUAXUSjLHxvEYApuZRU5nNWEZRnnxVsT8mVbWPl_RlyRN7tifBOpbkM3bnKdWlrA7bIizyaL23UJwJ5ttHMVsTNbnPV5XjL8uMyi4cY5aVzz4uZmvST3RF4fnAl3SA7W15vuFaCudfs6L62_ZTQsEQ priority: 102 providerName: ProQuest |
Title | Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31779588 https://www.proquest.com/docview/2328293572 https://www.proquest.com/docview/2320379993 https://pubmed.ncbi.nlm.nih.gov/PMC6883689 https://doaj.org/article/3746be5c8080426da871c49bdca5b5a7 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ra9RAEB_6APGL-G60HisIghDNY18RSulJSxGuSPHg8Muy2U1a4cjp9U60H_q3O7PJnRcsgl8OLrsJ2Z2Z3d9mfjMD8Io7WXjv69glpYzxn4h1pkTsfEqXcy5D-NjoTJ6O-ceJmGzBqrxVN4FXtx7tqJ7UeD59-_P7r0M0-INg8Fq-u8I1VhHBgBL7izyW27CLG5OiggYj_sepoHRgfKS4HseIOtLOyXnrI3rbVMjm__eavbFp9QmVGzvUyX2410FLdtTqwgPYqpqHcGfUOc8fwc2GKFjHz2IUXo5w07PAYGcdg51NiUvEbONZM2ti1MYfRFdlNhT5YDXFCUxbFt17ZlnreGAUqsIQUDLUu-bi-nK2ZFQve8FCDtvHMD45_vzhNO7KL8QOYdAizrlNdFWnRa18qisnbKnTPOVVmlhXi1LKLKG6HRllyOE4t8r6uuJ1nhQ-y2qXP4EdfMdqDxivBLFTyEeZ8DSVJaIEkZUWwQE-OeMRJKvZNq7LTU4lMqYmnFG0NK2ADArIkICMjODN-pZvbWKOf3UekgjXHSmndrgwm1-YzkRNrrgsK-Eo0ybiFm_xLOl4UXpnRSmsiuA1KYAhXcSXc7YLYMAhUg4tcyQJnnE8sEWw3-uJFuv6zSsVMiuFN4hsNUIvobD55bqZ7iQWXFPNlqFPkiuE9HkET1uNWw8JcaAqhNYRqJ4u9sbcb2m-XoZ84lLrXOri2f_M6HO4mwVrQVPS-7CzmC-rFwjPFuUAttVEDWB3eHz26XwQPnIMgiHi7_nwy2-VYzj8 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4k2ggJFASEhRE8evICFUHtWWdntqpb0Zx3ZapFVSursgOPCT-I3MONllI6Teekw8iezMeB7xNzOEvOBOlt77OnVZJVO4EqlmSqTO53i74DKmj40P5eiYf56IyQb5s8yFQVjlUidGRe1bh__It8HyazBNQrF3Z99S7BqFp6vLFhqdWOyHnz8gZJu93fsI_H3J2O6now-jtO8qkDqw7vO04DbToc7LWvlcBydspfMi5yHPrKtFJSXLsB0Fw8IvXGelsr4OvC6y0jNWuwLee4VcBcObYbCnJqsAL1dA3Z-c5lpuz0D3KwQ-YMMBUaRyYPtii4D_DcGaJRyiNNfM3u4tcrP3V-lOJ2C3yUZo7pBr4_5E_i75vcZf2oO-KOasgw_raYTF0x4WT6cIUKK28bRpmxRE_DtiYKmNnUNojckH0w6a94Za2p1mUMx_oeClUhDm5uTXabug2IR7TmNh3Hvk-FK-_n2yCXMMDwnlQSDkBQ8-M57nsgLXQ7DKgscBb2Y8IdnyaxvXFzzHvhtTEwMfLU3HIAMMMsggIxPyevXIWVft4yLi98jCFSEW6o432vMT0-97UyguqyAclu8EZ8hbCFAdLyvvrKiEVQl5hQJgUJ3A5JztsyJgiViYy-xI9Pk4RIEJ2RpQghpww-GlCJleDc3Mv02TkOerYXwSoXVNaBeRJisUxAlFQh50ErdaEjiXqhRaJ0QNZHGw5uFI8_U0FimXWhdSl48untYzcn10ND4wB3uH-4_JDRb3Sp4yvUU25-eL8AQ8vnn1NG4zSr5c9r7-C7J0Z9o |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+elevated+blood+glucose+level+and+non-valvular+atrial+fibrillation%3A+a+report+from+the+Guangzhou+heart+study&rft.jtitle=BMC+cardiovascular+disorders&rft.au=Fu%2C+Lu&rft.au=Deng%2C+Hai&rft.au=Lin%2C+Wei-dong&rft.au=He%2C+Shang-fei&rft.date=2019-11-28&rft.issn=1471-2261&rft.eissn=1471-2261&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12872-019-1253-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12872_019_1253_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2261&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2261&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2261&client=summon |